This Viewpoint proposes that standards for interpretation of genetic variants be expanded to include protective as well as pathogenic variants and stresses the importance of considering protective variants for assessing disease risk and guiding clinical decision making.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: